| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Matthew Robert Leonard CEO | XFRA Exchange | AU000000SCU9 ISIN |
| Australia Country | - Employees | 10 Jan 2005 Last Dividend | 28 May 2024 Last Split | - IPO Date |
BPH Global Ltd is a distinguished entity that engages in a spectrum of activities encompassing sourcing, production, marketing, and distribution of traditional medicines. This dynamic enterprise operates within a diverse geographical scope that includes Australia, Singapore, China, and Malaysia, marking its presence as a significant player in the traditional medicine industry. Originally established in 1984 and headquartered in Melbourne, Australia, the company embarked on its journey under the name Stemcell United Limited. It was not until June 2023 that a pivotal rebranding took place, introducing the world to BPH Global Ltd. This strategic renaming reflects the company's evolving focus and commitment to global health solutions through the lens of traditional medicine.
The portfolio of BPH Global Ltd is curated with a focus on harnessing the therapeutic virtues of traditional and natural products, ensuring a blend of efficacy and purity: